RxDoctor Payments Data

David Gallardo, MD

Radiation Oncology · Tulare, CANPI 1114913282

Payments from drug & device makers

$248in general payments, 2019–2025

Across 6 payments — averaging $41.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$92
  • Brainlab, Inc.$74
  • AstraZeneca$63
  • Boston Scientific$18

What the payments were for

  • Food & beverage$15563%
  • Education$9237%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$248 in reported general payments places this provider in the 35th percentile of 627 radiation oncology providers in California.

See all radiation oncology providers in California

Medicare billing

Part B allowed, 2024
$652,071
Medicare patients
220
Services billed
4,575

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl12$191

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Tulare

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →